| 1 |
29717476 | Physiologically Based Pharmacokinetic Modeling for Olaparib Dosing Recommendations: Bridging Formulations, Drug Interactions, and Patient Populations. | 2019 Jan |
4 |
| 2 |
28657402 | In vitro evaluation of the inhibition and induction potential of olaparib, a potent poly(ADP-ribose) polymerase inhibitor, on cytochrome P450. | 2018 Jun |
3 |
| 3 |
30730634 | Olaparib (LYNPARZAO) Ovarian cancer: spare patients who are in remission. | 2017 Jan |
1 |
| 4 |
27745744 | Effect of Itraconazole and Rifampin on the Pharmacokinetics of Olaparib in Patients With Advanced Solid Tumors: Results of Two Phase I Open-label Studies. | 2016 Oct |
5 |